ACORAMIDIS HYDROCHLORIDE

ACORAMIDIS HYDROCHLORIDE was reported 370 times

ACORAMIDIS HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HETEROGENEOUS TESTIS 1 0.5000
1 BLEEDING TIME 1 0.1429
2 PREALBUMIN INCREASED 1 0.0455
3 ACQUIRED ATTR AMYLOIDOSIS 1 0.0244
4 VENTRICULAR INTERNAL DIAMETER ABNORMAL 1 0.0105
5 PREALBUMIN DECREASED 1 0.0083
6 PANCREATIC ABSCESS 1 0.0050
7 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 1 0.0044
8 ENVIRONMENTAL EXPOSURE 1 0.0042
9 BETA 2 MICROGLOBULIN INCREASED 1 0.0038
10 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
11 PNEUMONITIS ASPIRATION 1 0.0029
12 PRODUCT PACKAGING DIFFICULT TO OPEN 7 0.0027
13 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 1 0.0024
14 URGE INCONTINENCE 2 0.0023
15 IMMUNOGLOBULINS INCREASED 1 0.0021
16 BLOOD CREATINE ABNORMAL 1 0.0021
17 AUTONOMIC NEUROPATHY 2 0.0020
18 HEAT ILLNESS 1 0.0015
19 PRODUCT TEMPERATURE EXCURSION ISSUE 7 0.0014
20 HEART SOUNDS ABNORMAL 1 0.0013
21 VASOCONSTRICTION 1 0.0011
22 INTUSSUSCEPTION 1 0.0010
23 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
24 PRODUCT BLISTER PACKAGING ISSUE 1 0.0010
25 BLOOD SODIUM ABNORMAL 1 0.0009
26 CARDIAC HYPERTROPHY 1 0.0009
27 RECTAL TENESMUS 1 0.0008
28 PROTEIN TOTAL ABNORMAL 1 0.0008
29 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
30 PRODUCT SIZE ISSUE 4 0.0007
31 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
32 GENITAL RASH 1 0.0007
33 MEDICAL DEVICE IMPLANTATION 1 0.0006
34 LEFT VENTRICULAR FAILURE 2 0.0006
35 AMYLOIDOSIS 1 0.0006
36 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
37 PRODUCT STORAGE ISSUE 2 0.0005
38 PANCREATIC CYST 1 0.0005
39 SPINAL STENOSIS 2 0.0005
40 ATRIAL THROMBOSIS 1 0.0005
41 WALKING DISABILITY 1 0.0005
42 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
43 MENOPAUSAL SYMPTOMS 1 0.0004
44 RETINAL ARTERY OCCLUSION 1 0.0004
45 BLOOD POTASSIUM ABNORMAL 1 0.0004
46 RASH MORBILLIFORM 1 0.0004
47 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
48 BRADYKINESIA 2 0.0003
49 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
50 BLOOD CREATININE INCREASED 21 0.0003
51 FOREIGN BODY IN THROAT 1 0.0003
52 NON-CARDIAC CHEST PAIN 1 0.0003
53 PRODUCT PACKAGING ISSUE 3 0.0003
54 CARDIAC FAILURE ACUTE 2 0.0003
55 LYME DISEASE 1 0.0003
56 DEPRESSIVE SYMPTOM 1 0.0003
57 PRODUCT SUPPLY ISSUE 2 0.0003
58 CAROTID ARTERY OCCLUSION 1 0.0003
59 FEELING DRUNK 2 0.0003
60 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
61 EPIGASTRIC DISCOMFORT 1 0.0003
62 SKIN ODOUR ABNORMAL 1 0.0003
63 BLOOD POTASSIUM INCREASED 4 0.0002
64 SLEEP TERROR 1 0.0002
65 BLOOD CREATINE INCREASED 1 0.0002
66 URINE ABNORMALITY 1 0.0002
67 COLITIS MICROSCOPIC 1 0.0002
68 PROTEIN URINE PRESENT 1 0.0002
69 FLUID INTAKE REDUCED 1 0.0002
70 TOXIC ENCEPHALOPATHY 1 0.0002
71 FAILURE TO THRIVE 1 0.0002
72 EXERCISE TOLERANCE DECREASED 1 0.0002
73 ORTHOSTATIC HYPOTENSION 3 0.0002
74 STRESS CARDIOMYOPATHY 1 0.0002
75 PRODUCT LABEL CONFUSION 1 0.0002
76 PRE-EXISTING CONDITION IMPROVED 1 0.0002
77 HAEMOGLOBIN ABNORMAL 1 0.0002
78 PRODUCT LABEL ISSUE 1 0.0001
79 LARGE INTESTINE POLYP 1 0.0001
80 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
81 FAECES SOFT 1 0.0001
82 RASH PUSTULAR 1 0.0001
83 APATHY 2 0.0001
84 INSURANCE ISSUE 2 0.0001
85 THYROID DISORDER 2 0.0001
86 APNOEA 1 0.0001
87 BRAIN FOG 2 0.0001
88 PRODUCT USE COMPLAINT 2 0.0001
89 TRICUSPID VALVE INCOMPETENCE 1 0.0001
90 ATRIAL FLUTTER 1 0.0001
91 RHINITIS 1 0.0001
92 THERAPY CESSATION 6 0.0001
93 GROIN PAIN 1 0.0001
94 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
95 ANAL INCONTINENCE 1 0.0001
96 OROPHARYNGEAL DISCOMFORT 1 0.0001
97 ABDOMINAL DISCOMFORT 18 0.0001
98 DIARRHOEA 69 0.0001
99 INTENTIONAL DOSE OMISSION 3 0.0001
100 PROTEINURIA 2 0.0001
101 LETHARGY 6 0.0001
102 ACUTE RESPIRATORY FAILURE 2 0.0001
103 DIZZINESS POSTURAL 1 0.0001
104 PRODUCT STORAGE ERROR 9 0.0001
105 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
106 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
107 THERAPY CHANGE 1 0.0001
108 HOSPICE CARE 1 0.0001
109 INABILITY TO AFFORD MEDICATION 1 0.0001
110 GASTROINTESTINAL DISORDER 9 0.0001
111 HYPOTHERMIA 1 0.0001
112 TEMPERATURE INTOLERANCE 1 0.0001
113 POOR VENOUS ACCESS 1 0.0001
114 DYSPHAGIA 9 0.0001
115 RETCHING 2 0.0001
116 FAECES DISCOLOURED 2 0.0001
117 BACK INJURY 1 0.0001
118 OESOPHAGITIS 1 0.0001
119 ASPIRATION 1 0.0001
120 LIP SWELLING 3 0.0001
121 NEPHROPATHY TOXIC 1 0.0001
122 MITRAL VALVE INCOMPETENCE 1 0.0001
123 DERMATITIS CONTACT 1 0.0001
124 NEURALGIA 2 0.0001
125 CARDIOMEGALY 1 0.0001
126 SMALL INTESTINAL OBSTRUCTION 1 0.0001
127 CYST 1 0.0001
128 DYSPNOEA EXERTIONAL 3 0.0001
129 ABDOMINAL PAIN LOWER 2 0.0001
130 MUSCLE ATROPHY 1 0.0001
131 PULMONARY CONGESTION 1 0.0001
132 MENTAL STATUS CHANGES 2 0.0001
133 APHONIA 1 0.0001
134 RENAL IMPAIRMENT 6 0.0001
135 CARPAL TUNNEL SYNDROME 1 0.0001
136 CARDIOGENIC SHOCK 1 0.0001
137 PARAESTHESIA ORAL 1 0.0001
138 HYPERTHYROIDISM 1 0.0001
139 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
140 GASTROENTERITIS 1 0.0001
141 CARDIOMYOPATHY 1 0.0001
142 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
143 COLON CANCER 1 0.0001
144 HAEMORRHAGE INTRACRANIAL 1 0.0001
145 THROAT IRRITATION 3 0.0001
146 MUSCULOSKELETAL CHEST PAIN 1 0.0001
147 EJECTION FRACTION DECREASED 1 0.0001
148 ABDOMINAL PAIN UPPER 13 0.0001
149 SCIATICA 1 0.0001
150 DYSPEPSIA 6 0.0001
151 BLOOD PRESSURE DECREASED 4 0.0001
152 VIRAL INFECTION 2 0.0001
153 CANDIDA INFECTION 1 0.0001
154 WEIGHT DECREASED 16 0.0001
155 CEREBRAL HAEMORRHAGE 2 0.0001
156 GOUT 1 0.0001
157 RESTLESS LEGS SYNDROME 1 0.0001
158 END STAGE RENAL DISEASE 1 0.0001
159 EYE SWELLING 2 0.0001
160 HYPONATRAEMIA 3 0.0001
161 PHOTOPHOBIA 1 0.0001
162 FLATULENCE 3 0.0001
163 HYPOCALCAEMIA 1 0.0001
164 BLOOD URINE PRESENT 1 0.0001
165 ATRIAL FIBRILLATION 5 0.0001
166 DYSPHONIA 3 0.0001
167 PRODUCT DOSE OMISSION ISSUE 15 0.0001
168 PRESCRIBED UNDERDOSE 1 0.0001
169 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
170 RIB FRACTURE 1 0.0000
171 ABDOMINAL DISTENSION 5 0.0000
172 EATING DISORDER 1 0.0000
173 POOR QUALITY SLEEP 1 0.0000
174 BALANCE DISORDER 4 0.0000
175 DIZZINESS 23 0.0000
176 ACUTE KIDNEY INJURY 7 0.0000
177 RASH MACULO-PAPULAR 1 0.0000
178 PULMONARY OEDEMA 2 0.0000
179 CHROMATURIA 1 0.0000
180 HEPATIC ENZYME INCREASED 3 0.0000
181 NEPHROLITHIASIS 2 0.0000
182 SKIN DISCOLOURATION 2 0.0000
183 CARDIAC DISORDER 4 0.0000
184 ARRHYTHMIA 2 0.0000
185 PRODUCTIVE COUGH 2 0.0000
186 BLOOD PRESSURE FLUCTUATION 1 0.0000
187 LOCALISED INFECTION 1 0.0000
188 MENTAL IMPAIRMENT 1 0.0000
189 UNDERDOSE 3 0.0000
190 LIVER INJURY 1 0.0000
191 AGEUSIA 1 0.0000
192 ASTHENIA 15 0.0000
193 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
194 HYPOPHAGIA 1 0.0000
195 ERECTILE DYSFUNCTION 1 0.0000
196 ILLNESS 4 0.0000
197 CARDIAC FAILURE 3 0.0000
198 FATIGUE 29 0.0000
199 BLOOD BILIRUBIN INCREASED 1 0.0000
200 THROAT TIGHTNESS 1 0.0000
201 HAEMOPTYSIS 1 0.0000
202 DEMENTIA 1 0.0000
203 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
204 SOMNOLENCE 7 0.0000
205 DECREASED APPETITE 8 0.0000
206 ABDOMINAL PAIN 8 0.0000
207 DYSSTASIA 1 0.0000
208 RENAL INJURY 1 0.0000
209 HYPOAESTHESIA 5 0.0000
210 CORONARY ARTERY DISEASE 1 0.0000
211 LIMB DISCOMFORT 1 0.0000
212 FEMUR FRACTURE 1 0.0000
213 CONSTIPATION 7 0.0000
214 NERVOUS SYSTEM DISORDER 1 0.0000
215 BONE DENSITY DECREASED 1 0.0000
216 GAIT DISTURBANCE 6 0.0000
217 HIP FRACTURE 1 0.0000
218 NIGHT SWEATS 1 0.0000
219 AMNESIA 2 0.0000
220 SWELLING FACE 2 0.0000
221 EYE DISORDER 1 0.0000
222 TREMOR 5 0.0000
223 RENAL FAILURE 4 0.0000
224 DEHYDRATION 4 0.0000
225 SYNCOPE 3 0.0000
226 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
227 CHEST DISCOMFORT 3 0.0000
228 DELIRIUM 1 0.0000
229 HEART RATE DECREASED 1 0.0000
230 DYSPNOEA 16 0.0000
231 THERAPY INTERRUPTED 2 0.0000
232 DYSURIA 1 0.0000
233 DYSGEUSIA 2 0.0000
234 DYSARTHRIA 1 0.0000
235 INTESTINAL OBSTRUCTION 1 0.0000
236 UNEVALUABLE EVENT 2 0.0000
237 MUSCULAR WEAKNESS 3 0.0000
238 COLITIS 1 0.0000
239 HOSPITALISATION 4 0.0000
240 BACK PAIN 6 0.0000
241 ABNORMAL BEHAVIOUR 1 0.0000
242 DISORIENTATION 1 0.0000
243 RASH 11 0.0000
244 DRY MOUTH 2 0.0000
245 POLLAKIURIA 1 0.0000
246 ROAD TRAFFIC ACCIDENT 1 0.0000
247 PRURITUS 9 0.0000
248 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
249 NAUSEA 18 0.0000
250 SUICIDAL IDEATION 2 0.0000
251 MUSCLE SPASMS 4 0.0000
252 ADVERSE EVENT 2 0.0000
253 RENAL DISORDER 1 0.0000
254 COGNITIVE DISORDER 1 0.0000
255 PRODUCT USE ISSUE 4 0.0000
256 OCULAR HYPERAEMIA 1 0.0000
257 ANAEMIA 4 0.0000
258 RASH ERYTHEMATOUS 1 0.0000
259 CONTUSION 2 0.0000
260 LEUKOPENIA 1 0.0000
261 AGGRESSION 1 0.0000
262 FLUID RETENTION 1 0.0000
263 BLOOD PRESSURE INCREASED 3 0.0000
264 ARTHRALGIA 8 0.0000
265 MUSCULOSKELETAL PAIN 1 0.0000
266 PANCREATITIS 1 0.0000
267 DEPRESSED MOOD 1 0.0000
268 DRUG INTERACTION 3 0.0000
269 BRADYCARDIA 1 0.0000
270 DISTURBANCE IN ATTENTION 1 0.0000
271 OEDEMA 1 0.0000
272 MALAISE 8 0.0000
273 FALL 6 0.0000
274 URTICARIA 3 0.0000
275 NECK PAIN 1 0.0000
276 COUGH 5 0.0000
277 OXYGEN SATURATION DECREASED 1 0.0000
278 URINARY TRACT INFECTION 3 0.0000
279 PALPITATIONS 2 0.0000
280 CHILLS 2 0.0000
281 SURGERY 1 0.0000
282 NASAL CONGESTION 1 0.0000
283 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
284 IRRITABILITY 1 0.0000
285 SUICIDE ATTEMPT 1 0.0000
286 STOMATITIS 1 0.0000
287 ILL-DEFINED DISORDER 1 0.0000
288 PLEURAL EFFUSION 1 0.0000
289 DISCOMFORT 1 0.0000
290 FEELING HOT 1 0.0000
291 CHEST PAIN 3 0.0000
292 RHINORRHOEA 1 0.0000
293 DRY SKIN 2 0.0000
294 HYPOTENSION 3 0.0000
295 VOMITING 7 0.0000
296 BURNING SENSATION 1 0.0000
297 SLEEP DISORDER 1 0.0000
298 HYPERTENSION 3 0.0000
299 ANXIETY 4 0.0000
300 MOBILITY DECREASED 1 0.0000
301 WEIGHT INCREASED 3 0.0000
302 HALLUCINATION 1 0.0000
303 CHRONIC KIDNEY DISEASE 1 0.0000
304 CONDITION AGGRAVATED 4 0.0000
305 PERIPHERAL SWELLING 2 0.0000
306 CARDIAC FAILURE CONGESTIVE 1 0.0000
307 CONFUSIONAL STATE 2 0.0000
308 INFLUENZA LIKE ILLNESS 1 0.0000
309 CEREBROVASCULAR ACCIDENT 2 0.0000
310 INTENTIONAL PRODUCT MISUSE 1 0.0000
311 MUSCULOSKELETAL STIFFNESS 1 0.0000
312 INSOMNIA 3 0.0000
313 TACHYCARDIA 1 0.0000
314 DEVICE ISSUE 1 0.0000
315 BLOOD GLUCOSE INCREASED 2 0.0000
316 PULMONARY EMBOLISM 1 0.0000
317 NEUROPATHY PERIPHERAL 1 0.0000
318 DEATH 9 0.0000
319 ALOPECIA 2 0.0000
320 PAIN IN EXTREMITY 3 0.0000
321 ERYTHEMA 2 0.0000
322 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
323 INFLUENZA 1 0.0000
324 SEPSIS 1 0.0000
325 ASTHMA 1 0.0000
326 JOINT SWELLING 1 0.0000
327 OEDEMA PERIPHERAL 1 0.0000
328 PAIN 5 0.0000
329 HEADACHE 5 0.0000
330 LOSS OF CONSCIOUSNESS 1 0.0000
331 MEMORY IMPAIRMENT 1 0.0000
332 PARAESTHESIA 1 0.0000
333 TOXICITY TO VARIOUS AGENTS 1 0.0000
334 MYALGIA 1 0.0000
335 MYOCARDIAL INFARCTION 1 0.0000
336 NO ADVERSE EVENT 1 0.0000
337 NASOPHARYNGITIS 1 0.0000
338 HYPERSENSITIVITY 1 0.0000
339 OVERDOSE 1 0.0000
340 DEPRESSION 1 0.0000
341 FEELING ABNORMAL 1 0.0000
342 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
343 INJECTION SITE PAIN 1 0.0000
344 PNEUMONIA 1 0.0000
345 PYREXIA 1 0.0000
346 DRUG INEFFECTIVE 2 0.0000
347 OFF LABEL USE 1 0.0000